Dr. Rob Carlson, MD FACS (Full CV)
Cum Laude, May 1979
Ohio State School of Dentistry
Wright State School of Medicine
M.D., 1986- Graduated in top 15%
INTERNSHIP: University of Florida- Shands Hospital
General Surgery, 1986-1987
RESIDENCY: University of Florida- Shands Hospital
Gainesville, Fl General Surgery, 1987-1982
Woodward Award- Top Surgical Resident
FELLOWSHIP: University of Florida- Shands Hospital
Gainesville, Fl Cardiothoracic Surgery, 1992-1994
LICENSURE: Florida – ME: 0051783 Diplomat of National Board of Medical Examiners:
Successful Completion Parts I, II and III
CERTIFICATION: American Board of Surgery, 2/94
American Board of Thoracic Surgery, 6/2/95
Advanced Cardiac Life Support, 2/08
RECERTIFICATION: American Board of Surgery, 12/03
American Board of Thoracic Surgery, 12/03
FELLOW AMERICAN COLLEGE OF SURGEONS
EMPLOYMENT: Robert G. Carlson, MD, FACS, Andlos Institute of Age Management
2914 Bee Ridge Road
Sarasota, FL 34239 (present)
Gulf Coast Heart and Lung Surgery
1762 Hawthorne Street, Suite 4
Sarasota, FL 34239
1880 Arlington Street, Suite 103
Sarasota, FL 34239 (September 1996- September 1999)
- Recipient of the 1990 Resident Award for Outstanding Research from the Society for Surgery of the Alimentary tract
- Radiological Sciences Award; 1983, 1986
- American Heart Association Research Fellowship; 1983, 1985
- National Resident Research Award; University of Florida, 1991
- Top Surgical Resident University of Florida 1992, Edward Woodward Surgical Resident Award.
- “America’s Top Surgeons” 2002-2003 Edition. Guide to America’s Top Surgeons, Consumer Research Council of America
- 2005 Physician of the Year, NRCC award
- “America’s Top Doctors” 2006-2007 Edition. Guide to America’s Top Doctors, Castle Connolly Medical LTD.
- “America’s Top Surgeons” 2009-2010 Edition. Guide to America’s Top Surgeons, Castle Connolly Medical LTD.
- Man of the Year in Medicine & Healthcare 2010. American Biographical Institute.
Department Chairman- Department of Surgery, Columbia Doctors Hospital 1997-1999
American College of Surgeons
Florida Medical Society
Florida Society of Thoracic Surgeons
American College of Phlebology
Sarasota Memorial Hospital- Medical Staff (semi-retired(resigned-December 2008)
Columbia Doctors Hospital- Medical Staff (semi-retired(resigned)
Nationally recognized expert witness with testimony/case review in:
- West Virginia
- North Carolina
- South Carolina
- South Dakota
- Washington D.C.
1. Carlson RG, Morath MA, Finley RK, Jr., Miller SF, et al: Fluid retention during the
first 48 hours as an indicator of burn survival. (Abstract) Proceedings of the
American Burn Association 16:105, 1984.
2. Carlson RG, Miller SF, Finley RK, Jr., and Jones LM: The relationship of body
surface area to fluid dynamics in severely burned patients. (Abstract) Clinical
Research 33 (4): 927A, 1985.
3. Carlson RG, Miller SF, Finley RK, Jr., et al: Fluid retention and burn patient survival.
(abstract ) Proceedings of the American Burn Association 18:6, 1986.
4. Carlson RG, Finley RK, Jr., Miller SK, et al: Fluid retention during the first 48 hours
as an indicator of burn survival. J Trauma 26:840-843, 1986.
5. Carlson RG, Miller SF, Finley RK, Jr., Billett JM, et al: Fluid retention and burn
patient survival. J Trauma 27: 127-135,1987.
6. Carlson RG, Bagwell CE, Talbert JL: Giant breast mass in an adolescent female.
Contemporary Surgery 35: 75-77, 1989.
7. Carlson RG, Fegelman E, Finley RK, Jr., Miller, SF: Assessment of the total body
water in burn patients using bioelectric impedance analysis. Submitted to the Journal
of Burn Care and Rehabilitation
8. Carlson RG, Mayfield WR, Normann S, Alexander JA: Radiation associated valvular
heart disease. Chest 545, 1991.
9. Hocking MP, Carlson RG, Courington KR, Bland KI: Altered motility and bacterial
flora following “functional end-to-end anastomosis”. Surgery 108(2) : 384-392, 1990.
10. Carlson RG, Hocking MP, Courington KR, Sninsky CA, Vogel SB: Erythromycin
enhances gastric emptying in Roux-en-Y dogs with delayed gastric emptying. AM J
Surg 161:31-35, 1990.
11. Hocking MP, Carlson RG, Harrison WE, Sninsky Ca, Vogel SB; Radionuclide gastric
emptying, gastric myoelectric activity and the effect of electrical pacing after gastric
surgery. Surg Forum XLT: 125-127,1990.
12. Carlson RG, Hocking MP, Sninsky CA, Vogel SB: Erythromycin acts through a
cholinergic pathway to improve canine delayed gastric emptying following vagotomy
and Roux-en-Y antrectomy. J Surg Res 50: 494-498, 1991.
13. Hocking MP, Carlson RG, Vogel SB: Selective vagotomy does not prevent delayed
gastric emptying and altered myoelectric activity following Roux-en-Y gastrojejunostomy. AM J Surg (submitted for publication).
14. Carlson RG, Schiro, JC, Hertz C: Complete Myocardial Revascularization Is Safe
Using Off -Pump Techniques in High Risk Elderly Patients. Am College of
Cardiology (submitted for publication).
15. Sidney F. Miller,a M.D., Robert G Carlson, M.D. ,b Elliott Fegelman, M.D., c Jose
Quinones, M.D. d and Robert K. Finley, Jr., M.D. a Dayton, Ohio. A comparison of
Total Body Water Analyses: Bioelectric Impedance analysis Versus the Tritiate Water
Method. American Burn Association, 1999.
16. Carlson RG, Schiro JC, Hertz C: Off-pump Coronary Artery Bypass in
Octogenarians. MICS Symposium, May 25-27, 2000. (Abstract presentation ).
17. Carlson RG, O’Brien DJ, Knauf, DG. Radiation Heart Disease. In J.Willis Hurst: New
Types of Cardiovascular Diseases, New York, Igaku-Shoin, 1994, p 225-239.
1. Fluid retention during the first 48 hours as an indicator of burn survival. Presented at
the 16th Annual American Burn Association Meeting, San Francisco, CA, March 1984.
2. The relationship of body surface area to fluid dynamics in severely burned patients.
Presented at the Midwest Medical Student Research Forum, Dayton, OH. May 1985.
3. Fluid retention and burn patient survival. Presented at the 18th Annual American Burn
Association Meeting, Chicago, IL. April 1986.
4. Fluid retention and burn patient survival. Poster session at the 72nd Annual Clinical
Congress of the American College of Surgeons, New Orleans, LA. October 1986.
5. Impedance and titrated water determinations of total body water in severely burned
patients. Presented at the American College of Surgeons, Committee of Trauma,
Florida Chapter. November 1988.
6. Erythromycin enhances gastric emptying in Roux-Y dogs with severe gastroparesis.
Presented at the Society of University Resident’s Program, Los Angeles, CA.
7. Erythromycin enhances gastric emptying in Roux-Y dogs with severe delayed gastric
emptying. Presented at the Society for Surgery of the Alimentary Tract, San Antonio,
TX. May 1990.
8. Erythromycin acts through a cholinergic mechanism to improve delayed gastric
emptying following vagotomy and Roux-Y antrectomy. Presented to the Association
of Academic Surgery, November 1990.
9. Complete coronary artery revascularization using off-pump techniques in elderly
patients. Presented at Utrecht Workshop. Universitair Medisch Centrum, Utrecht,
Netherlands. September 4, 1999.
10. Protecting Your Heart with Proper Hormone Replacement Therapy. 4th Annual
International Congress on Anti-Aging Medicine and Regenerative Biomedical
Technologies. Las Vegas, Nevada December 7-10, 2006.
1. Aventis Trial HOE 642/3002. “A double- blind, placebo-controlled, multi-national trial to
investigate the effect of IV treatment with the Na+/H+ exchange inhibitor cariporide
(HOE642) on all-cause mortality and myocardial infarction in patients at risk of
myocardial necrosis during and after coronary artery bypass graft (CABG) surgery”
2. PERFECT: Perma Flow CABG Trial. Possis Medical Inc. Perma Flow Synthetic PTFE
Vascular Graft SMH IRB 96-CARD-21
3. A Phase III Randomized, Parallel, Double-Blind, Multi-Center, Placebo-Controlled Study
of the Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients
Undergoing Coronary Artery Bypass Graft (CABG) Surgery with Cardiopulmonary
Bypass. Procter & Gamble Pharmaceuticals, Alexion Pharmaceuticals, Inc. Pexelizumab.
PRIMO CABG Protocol #2000099.
4. A Multi-Center, Randomized, Double-Blind, Parallel-group, Placebo-Controlled Study of 2
mg/kg bolus plus 24-hour 0.05 mh/kg/hr Infusion of Pexelizumab in Patients Undergoing
Coronary Artery Bypass Graft (CABG) Surgery with Cardiopulmonary Bypass. (Primo
2)Proctor & Gamble Pharmaceuticals, Alexion Pharmaceuticals, Inc- Pexelizumab. Primo
2 Coronary Artery Bypass High Risk Patients –Protocol Study
1. AVANT Immunotherapeutics, Inc. TP-10ACS-001.
A Study of the Safety and Efficacy of
TP-10 (SCR1) In the Prevention of Post Cardiopulmonary Bypass Syndromes In Adults.
2. OXYGENT TM CPB I 1999 Alliance Pharmaceuticals Corp., Protocol #OXHT-017-INT.
3. PROTOCOL# CGT003-04 A Phase III, Multi-Center,Randomized,Double-Blind Placebo
Controlled Trial Of EX-VIVO Treatment With CGT003 Of Coronary Vein Grafts In
Patients Undergoing Coronary Artery Bypass Grafting Procedures.
4. A Phase 2 Randomized Double-Blind, Placebo-Controlled Study of the Safety and Efficacy
of Recombinant Soluble Complement Receptor Type 1 (TP 10) in Adult women
Undergoing Cardiopulmonary Bypass Surgery.
5. A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
To Evaluate The Cardioprotective Effects of MC-1 In Patients Undergoing High-Risk
Coronary Artery Bypass Graft (CABG) Surgery. Mend-CABG II, Medicure International
Inc, Clinical Research Protocol # 06004